Ten years after the creation of Rutgers Biomedical and Health Sciences, new university institutes and centers are bringing the world’s best medical ideas to New Jersey and beyond
Tag: Translational Medicine
“COVID rebound” is common, even in untreated patients
“COVID rebound,” in which evidence of the illness disappears and then returns days or weeks later, is surprisingly common—whether or not patients are given the antiviral Paxlovid.
A New Way to Make Asthma Drugs Last Longer
New research into making asthma and COPD medication more potent could also improve how long they work in patients who need frequent doses
New gene editing strategy could lead to treatments for people born with inherited diseases of the immune system
A fault in cells that form a key part of the immune system can be repaired with a pioneering gene editing technique, finds new research demonstrated in human cells and mice, led by UCL scientists.
Stem Cell-Gene Therapy Shows Promise in ALS Safety Trial
Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig’s disease.
New Review Paper Proposes Framework for Advancing Application of Animal-to-Human Transplantation
“The potential for xenotransplantation to allow for an unlimited donor supply and resolve the organ shortage is now closer than ever,” according to a new paper published today in JACC: Basic to Translational Science.
UCI to lead transfer of UC COVID-19 patient information to federal database
Irvine, Calif., March 24, 2021 – Vaccines are here, but as COVID-19 cases continue and variants spread, researchers need easy access to a wide variety of data to better understand the disease. Led by the University of California, Irvine, UC hospitals have received a $500,000 grant from the National Institutes of Health to make this possible.
Radioactive bone cement found to be safer in treating spinal tumors
Irvine, Calif., Feb. 16, 2021 — A radioactive bone cement that’s injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers. The study shows that this brachytherapy cement can be placed into spinal bones to directly irradiate tumors without harming the spinal cord, and the radioactive material will stay localized in the bones, which promises to virtually eliminate side effects.
Kappa Delta Ann Doner Vaughn Award Presented to Cato T. Laurencin, MD, PhD, FAAOS for pioneering research in bone regenerative engineering
Cato T. Laurencin, MD, PhD, was named the 2021 Kappa Delta Ann Doner Vaughn Award recipient for his 30 years of scientific research in musculoskeletal regenerative engineering, the field which he founded and brought to the forefront of translational medicine.
Ionic liquid formulation uniformly delivers chemotherapy to tumors while destroying cancerous tissue
A Mayo Clinic team, led by Rahmi Oklu, M.D., Ph.D., a vascular and interventional radiologist at Mayo Clinic, in collaboration with Samir Mitragotri, Ph.D., of Harvard University, report the development of a new ionic liquid formulation that killed cancer cells and allowed uniform distribution of a chemotherapy drug into liver tumors and other solid tumors in the lab.
MD Anderson and Taiho Pharmaceutical announce collaboration to accelerate development of novel therapies for brain metastasis and other unmet medical needs
The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with brain metastases and those with cancers refractory to available therapies.
UCLA Health’s Dr. Clara Lajonchere elected Chair of the California Precision Medicine Advisory Council
Dr. Clara Lajonchere, deputy director of the Institute for Precision Health at UCLA Health, has been elected chair of the new California Precision Medicine Advisory Council.
The Tri-Institutional Therapeutics Discovery Institute, Inc. Renews Partnerships with Takeda and Bridge Medicines, LLC
To date, work done within the Tri-I TDI has resulted in the launch of two New York City–based companies and the licensing of six therapeutic discovery programs.
October’s SLAS Technology Special Issue Published
In the October Special Issue of SLAS Technology, Guest Editors Soojung Claire Hur, Ph.D., and Deok-Ho Kim, Ph.D., (Johns Hopkins University; Baltimore, MD, USA) introduce a collection of articles and reviews focused on the advancement in technologies that are playing a major role in shifting healthcare closer to more predictive, preventative and personalized medicine.